These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 16473278

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.
    Nacht M, Jacks T.
    Cell Growth Differ; 1998 Feb; 9(2):131-8. PubMed ID: 9486849
    [Abstract] [Full Text] [Related]

  • 3. p53-dependent and p53-independent pathways for radiation-induced immature thymocyte differentiation.
    Candéias SM, Mancini SJ, Touvrey C, Borel E, Jouvin-Marche E, Marche PN.
    Oncogene; 2004 Mar 11; 23(10):1922-9. PubMed ID: 14755249
    [Abstract] [Full Text] [Related]

  • 4. Functional interplay of p53 and Mus81 in DNA damage responses and cancer.
    Pamidi A, Cardoso R, Hakem A, Matysiak-Zablocki E, Poonepalli A, Tamblyn L, Perez-Ordonez B, Hande MP, Sanchez O, Hakem R.
    Cancer Res; 2007 Sep 15; 67(18):8527-35. PubMed ID: 17875692
    [Abstract] [Full Text] [Related]

  • 5. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
    Tsuji H, Ishii-Ohba H, Katsube T, Ukai H, Aizawa S, Doi M, Hioki K, Ogiu T.
    Cancer Res; 2004 Dec 15; 64(24):8882-90. PubMed ID: 15604248
    [Abstract] [Full Text] [Related]

  • 6. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
    Ward JM, Tadesse-Heath L, Perkins SN, Chattopadhyay SK, Hursting SD, Morse HC.
    Lab Invest; 1999 Jan 15; 79(1):3-14. PubMed ID: 9952106
    [Abstract] [Full Text] [Related]

  • 7. Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis.
    Cheung AM, Hande MP, Jalali F, Tsao MS, Skinnider B, Hirao A, McPherson JP, Karaskova J, Suzuki A, Wakeham A, You-Ten A, Elia A, Squire J, Bristow R, Hakem R, Mak TW.
    Cancer Res; 2002 Nov 01; 62(21):6194-204. PubMed ID: 12414647
    [Abstract] [Full Text] [Related]

  • 8. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
    Curtis DJ, Robb L, Strasser A, Begley CG.
    Oncogene; 1997 Dec 11; 15(24):2975-83. PubMed ID: 9416841
    [Abstract] [Full Text] [Related]

  • 9. Mutations in the p53 and scid genes do not cooperate in lymphomagenesis in doubly heterozygous mice.
    Kosugi S, Miyazawa T, Chou D, Saito Y, Shinbo T, Matsuki A, Okano H, Miyaji C, Watanabe H, Hatakeyama K, Niwa O, Kominami R.
    Biochem Biophys Res Commun; 1999 Feb 05; 255(1):99-103. PubMed ID: 10082662
    [Abstract] [Full Text] [Related]

  • 10. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
    Rowh MA, DeMicco A, Horowitz JE, Yin B, Yang-Iott KS, Fusello AM, Hobeika E, Reth M, Bassing CH.
    Oncogene; 2011 Nov 24; 30(47):4757-64. PubMed ID: 21625223
    [Abstract] [Full Text] [Related]

  • 11. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.
    De la Cueva E, García-Cao I, Herranz M, López P, García-Palencia P, Flores JM, Serrano M, Fernández-Piqueras J, Martín-Caballero J.
    Oncogene; 2006 Jul 06; 25(29):4128-32. PubMed ID: 16462758
    [Abstract] [Full Text] [Related]

  • 12. Accumulation of aberrant Y chromosomes in gamma-ray-induced thymic lymphomas lacking p53.
    Chou D, Matsuki J, Saitou Y, Kosugi SI, Shinbo T, Gejyo F, Niwa O, Kominami R.
    Mol Carcinog; 1999 Nov 06; 26(3):157-62. PubMed ID: 10559790
    [Abstract] [Full Text] [Related]

  • 13. TCR-mediated death of mature T lymphocytes occurs in the absence of p53.
    Boehme SA, Lenardo MJ.
    J Immunol; 1996 Jun 01; 156(11):4075-8. PubMed ID: 8666771
    [Abstract] [Full Text] [Related]

  • 14. Rag-dependent and Rag-independent mechanisms of Notch1 rearrangement in thymic lymphomas of Atm(-/-) and scid mice.
    Tsuji H, Ishii-Ohba H, Noda Y, Kubo E, Furuse T, Tatsumi K.
    Mutat Res; 2009 Jan 15; 660(1-2):22-32. PubMed ID: 19000702
    [Abstract] [Full Text] [Related]

  • 15. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
    Bi X, Feng D, Korczeniewska J, Alper N, Hu G, Barnes BJ.
    Oncogene; 2014 Jun 19; 33(25):3288-97. PubMed ID: 23912454
    [Abstract] [Full Text] [Related]

  • 16. Oncogene-induced senescence as an initial barrier in lymphoma development.
    Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dörken B, Jenuwein T, Schmitt CA.
    Nature; 2005 Aug 04; 436(7051):660-5. PubMed ID: 16079837
    [Abstract] [Full Text] [Related]

  • 17. Haploinsufficiency of Bcl11b for suppression of lymphomagenesis and thymocyte development.
    Kamimura K, Ohi H, Kubota T, Okazuka K, Yoshikai Y, Wakabayashi Y, Aoyagi Y, Mishima Y, Kominami R.
    Biochem Biophys Res Commun; 2007 Apr 06; 355(2):538-42. PubMed ID: 17306224
    [Abstract] [Full Text] [Related]

  • 18. New insights into the proliferation and differentiation of early mouse thymocytes.
    Laurent J, Bosco N, Marche PN, Ceredig R.
    Int Immunol; 2004 Aug 06; 16(8):1069-80. PubMed ID: 15197172
    [Abstract] [Full Text] [Related]

  • 19. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
    Bassing CH, Ranganath S, Murphy M, Savic V, Gleason M, Alt FW.
    Blood; 2008 Feb 15; 111(4):2163-9. PubMed ID: 17855626
    [Abstract] [Full Text] [Related]

  • 20. Clonally expanding thymocytes having lineage capability in gamma-ray-induced mouse atrophic thymus.
    Yamamoto T, Morita S, Go R, Obata M, Katsuragi Y, Fujita Y, Maeda Y, Yokoyama M, Aoyagi Y, Ichikawa H, Mishima Y, Kominami R.
    Int J Radiat Oncol Biol Phys; 2010 May 01; 77(1):235-43. PubMed ID: 20394855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.